Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study.
Devine
M L
ML
Dow
G J
GJ
Greenberg
B R
BR
Holstein
D W
DW
Icaza
L
L
Jue
P Y
PY
Meyers
F H
FH
O'Brien
E
E
Roberts
C M
CM
Rocchio
G L
GL
D000328:Adult; D000932:Antiemetics / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D013759:Dronabinol / Q000009:adverse effects*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D000932:Antiemetics; D000970:Antineoplastic Agents; D013759:Dronabinol